Veröffentlichungen | MDC Berlin

9 Ergebnisse:

Active Filter:

04. Juni 2015 in Mol Cell

Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed

A. Rybak-Wolf
C. Stottmeister
P. Glažar
M. Jens
N. Pino
S. Giusti
M. Hanan
M. Behm
O. Bartok
R. Ashwal-Fluss
M. Herzog
L. Schreyer
P. Papavasileiou
A. Ivanov
M. Öhman
D. Refojo
S. Kadener
N. Rajewsky

15. April 2015 in Int J Cancer

Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB

A. Flörcken
M. Grau
A. Wolf
A. Weilemann
J. Kopp
B. Dörken
T. Blankenstein
A. Pezzutto
P. Lenz
G. Lenz
J. Westermann

01. April 2015 in Curr Opin Immunol

Targeting cancer-specific mutations by T cell receptor gene therapy

T. Blankenstein
M. Leisegang
W. Uckert
H. Schreiber

01. April 2015 in Nat Biotechnol

Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice

M. Obenaus
C. Leitão
M. Leisegang
X. Chen
I. Gavvovidis
P. van der Bruggen
W. Uckert
D.J. Schendel
T. Blankenstein

13. Dezember 2011 in Canc Cell

Oncogene-targeting T cells reject large tumors while oncogene inactivation selects escape variants in mouse models of cancer

K. Anders
C. Buschow
A. Herrmann
A. Milojkovic
C. Loddenkemper
T. Kammertoens
P. Daniel
H. Yu
J. Charo
T. Blankenstein

01. November 2011 in Eur J Immunol

Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors

J. Charo
C. Perez
C. Buschow
A. Jukica
M. Czeh
T. Blankenstein

28. Juli 2011 in Blood

The only proposed T-cell epitope derived from the TEL-AML1 translocation is not naturally processed

J. Popovic
L.P. Li
P.M. Kloetzel
M. Leisegang
W. Uckert
T. Blankenstein

01. April 2011 in Gene Ther

Allogeneic gene-modified tumor cells (RCC-26/IL-7/CD80) as a vaccine in patients with metastatic renal cell cancer: a clinical phase-I study

J. Westermann
A. Floercken
G. Willimsky
A. van Lessen
J. Kopp
A. Takvorian
K. Joehrens
A. Lukowsky
C. Schoenemann
B. Sawitzki
H. Pohla
R. Frank
B. Doerken
D.J. Schendel
T. Blankenstein
A. Pezzutto

15. Januar 2011 in Int J Cancer

Tumor rejection by local interferon gamma induction in established tumors is associated with blood vessel destruction and necrosis

D. Briesemeister
D. Sommermeyer
C. Loddenkemper
R. Loew
W. Uckert
T. Blankenstein
T. Kammertoens